Amgen | Pre Utilidad Fiscal



Pre Tax Profit Cambio Fecha
AbbVie USD 1.66B 3.15B 2025-03
Agios Pharmaceuticals USD -112020000 22.73M 2025-06
ALKERMES USD 104.84M 79.35M 2025-06
Amgen USD 1.97B 1.41B 2025-03
Biogen USD 744M 432.8M 2025-06
BioMarin Pharmaceutical USD 238.09M 68.45M 2025-03
Bristol-Myers Squibb USD 1.77B 1.2B 2025-06
Eli Lilly USD 3.46B 2.08B 2025-03
Exelixis USD 230.42M 24.72M 2025-06
Genmab DKK 244M 3.36B 2025-03
Gilead Sciences USD 2.96B 112M 2024-12
GlaxoSmithKline GBP 1.89B 221M 2025-06
Glaxosmithkline USD 1.66B 1.78B 2024-12
Incyte USD 558.01M 323.82M 2025-06
Ionis Pharmaceuticals USD 124M 271M 2025-06
J&J USD 13.63B 8.21B 2025-03
Merck USD 6.77B 864M 2025-06
Moderna USD -818000000 146M 2025-06
Neurocrine Biosciences USD 159.5M 144.8M 2025-06
Novartis USD 4.53B 124M 2025-06
Novartis USD 4.66B 269M 2024-12
Pfizer USD 2.78B 1.65B 2025-03
PTC Therapeutics USD -94699000 3.29M 2024-12
Regeneron Pharmaceuticals USD 1.52B 613.7M 2025-06
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 1.42B 734M 2025-06
Sarepta Therapeutics USD -383518000 555.26M 2025-03
Takeda JPY 150.63B 257.93B 2025-06
Teva Pharmaceutical Industries USD 203M 91M 2025-06
Ultragenyx Pharmaceutical USD -149770000 16.37M 2025-03
Vertex Pharmaceuticals USD 730.4M 585.6M 2025-03


Amgen Pre Utilidad Fiscal - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.